American Thyroid Association guidelines for detection of thyroid dysfunction.

OBJECTIVE To define the optimal approach to identify patients with thyroid dysfunction. PARTICIPANTS The 8-member Standards of Care Committee of the American Thyroid Association prepared a draft, which was reviewed by the association's 780 members, 50 of whom responded with suggested revisions. EVIDENCE Relevant published studies were identified through MEDLINE and the association membership's personal resources. CONSENSUS PROCESS Consensus was reached at group meetings. The first draft was prepared by a single author (P.W.L.) after group discussion. Suggested revisions were incorporated after consideration by the committee. CONCLUSIONS The American Thyroid Association recommends that adults be screened for thyroid dysfunction by measurement of the serum thyrotropin concentration, beginning at age 35 years and every 5 years thereafter. The indication for screening is particularly compelling in women, but it can also be justified in men as a relatively cost-effective measure in the context of the periodic health examination. Individuals with symptoms and signs potentially attributable to thyroid dysfunction and those with risk factors for its development may require more frequent serum thyrotropin testing.

[1]  W. Patsch,et al.  Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. , 1990, Archives of internal medicine.

[2]  N. Bagchi,et al.  Thyroid dysfunction in adults over age 55 years. A study in an urban US community. , 1990, Archives of internal medicine.

[3]  A. Vita,et al.  Psychopathological and cognitive features in subclinical hypothyroidism , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  S. S. Stoffer,et al.  Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text , 2001 .

[5]  R. Westendorp,et al.  Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies , 1996, Clinical endocrinology.

[6]  B. Weintraub,et al.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. , 1992, The American journal of medicine.

[7]  K. Caidahl,et al.  A DOUBLE‐BLIND CROSS‐OVER 12‐MONTH STUDY OF l‐THYROXINE TREATMENT OF WOMEN WITH ‘SUBCLINICAL’ HYPOTHYROIDISM , 1988, Clinical endocrinology.

[8]  B. Biondi,et al.  Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. , 1994, The Journal of clinical endocrinology and metabolism.

[9]  R. Hanzlick,et al.  Improving the accuracy of death certificates. , 1993, JAMA.

[10]  Autopsy. A comprehensive review of current issues. Council on Scientific Affairs. , 1987, JAMA.

[11]  P. Mckelvie,et al.  Medical certification of causes of death in an Australian metropolitan hospital: Comparison with autopsy findings and a critical review , 1993, The Medical journal of Australia.

[12]  R. Hanzlick.  Protocol for writing cause-of-death statements for deaths due to natural causes. , 1996, Archives of internal medicine.

[13]  W. Castelli,et al.  The aging thyroid. Thyroid deficiency in the Framingham Study. , 1985, Archives of internal medicine.

[14]  D. Cooper,et al.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.

[15]  Randy Hanzlick,et al.  The Medical cause of death manual : instructions for writing cause of death statements for deaths due to natural causes , 1994 .

[16]  R. E. Anderson,et al.  Cause of death. Proper completion of the death certificate. , 1987, JAMA.

[17]  P. Ladenson,et al.  Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. , 1995, JAMA.

[18]  D. Schottenfeld,et al.  The autopsy as a measure of accuracy of the death certificate. , 1982, Bulletin of the New York Academy of Medicine.

[19]  G. Maudsley,et al.  "Inaccuracy' in death certification--where are we now? , 1996, Journal of public health medicine.

[20]  E. Mcgoogan,et al.  A prospective study of 1152 hospital autopsies: II. Analysis of inaccuracies in clinical diagnoses and their significance , 1981, The Journal of pathology.

[21]  U. P. S. T. Force.  Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .

[22]  J. Goodwin,et al.  Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. , 1987, JAMA.

[23]  C. Spencer,et al.  Current status and performance goals for serum thyrotropin (TSH) assays. , 1996, Clinical chemistry.

[24]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[25]  R. Hanzlick.  Death Certificates: The Need for Further Guidance , 1993 .

[26]  R. Hanzlick.  Improving the accuracy of death certificates. , 1993, JAMA.

[27]  C. Heathcote,et al.  A comparison of death certificates and autopsies in the Australian Capital Territory , 1992, The Medical journal of Australia.

[28]  N. Powe,et al.  Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. , 1996, JAMA.

[29]  A. Galløe,et al.  Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. , 1994, European journal of endocrinology.

[30]  J. Jónasson,et al.  The accuracy of death certificates. Implications for health statistics. , 1991, Virchows Archiv. A, Pathological anatomy and histopathology.

[31]  J. Jordan,et al.  Errors in death certificate completion in a teaching hospital. , 1993, Clinical and investigative medicine. Medecine clinique et experimentale.

[32]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[33]  R. Hanzlick.  Principles for including or excluding 'mechanisms' of death when writing cause-of-death statements. , 1997, Archives of pathology & laboratory medicine.

[34]  G. Klee,et al.  Biochemical testing of thyroid function. , 1997, Endocrinology and metabolism clinics of North America.

[35]  J. Franklyn,et al.  Thyroxine replacement therapy and circulating lipid concentrations , 1993, Clinical endocrinology.

[36]  A. El-Sayed,et al.  Reliability of death certificate diagnoses. , 1990, Journal of clinical epidemiology.

[37]  H. M. Cameron,et al.  A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification , 1981, The Journal of pathology.

[38]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[39]  Jordan Jm,et al.  Errors in death certificate completion in a teaching hospital. , 1993 .

[40]  B. Uzzan,et al.  Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. , 1996, The Journal of clinical endocrinology and metabolism.